We are partners to the entrepreneurs who are changing the face of medicine. As venture investors who play an active role in our companies, we diligently search for emerging technology offering the possibility of game-changing economic and social value. Our purpose is to de-risk medical technology to the point at which it is acceptable to regulatory agencies, decidedly beneficial to the end user, and is exceedingly attractive to potential acquirers. Our years of hands-on management experience, a track record of finding, funding, and developing great ideas and great companies, facilitate this process.
"BioVentures really understands how to build value around new medical technology"
Michael J. Magliochetti, Ph.D.
President and CEO
"BioVentures supports management with a wealth of industry knowledge and operating experience"
Rachiotek President and CEO
"I'd call BioVentures Investors a 'user-friendly' venture capital firm. They understand technology development timelines and the issues related to medical devices."
Steven J. Tallarida
President Spirus Medical and ,
Founder AngioLink Corporation.
"What really sets them apart is their maturity, their understanding of the whole world of start-ups and what it takes to get a new idea and technology off the ground."
President & CEO